Filter by: patients
What is Metformin?

Metformin an antidiabetic agent used for the management of type 2 diabetes mellitus (noninsulin dependent, NIDDM) as monotherapy when hyperglycemia (high blood sugar) cannot be managed with diet and exercise alone.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Diabetes Type 2 524 85 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 73 10 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
PCOS (Polycystic Ovary Syndrome) 59 14 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Diabetes Mellitus 23 2 Efficacy_major Efficacy_cant_tell
Polycystic Ovary Syndrome (PCOS) 19 7 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
General health 17 2 Efficacy_major

See all 735 patients currently taking Metformin

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
19
Moderate
20
Mild
45
None
57

Reported Dosages

Frequently reported dosages based on patients currently taking Metformin. See all 38 dosages

  500 mg/5 mL daily 500 mg daily 850 mg daily 1,000 mg daily 2 x 500 mg/5 mL daily 3 x 500 mg/5 mL daily 1,500 mg daily 1,700 mg daily 2,000 mg daily 4 x 500 mg/5 mL daily
  43 Number of Patients: 43 113 Number of Patients: 113 15 Number of Patients: 15 207 Number of Patients: 207 50 Number of Patients: 50 15 Number of Patients: 15 55 Number of Patients: 55 20 Number of Patients: 20 178 Number of Patients: 178 21 Number of Patients: 21  

Reported Stop Reasons

Why Patients Stopped Taking Metformin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 43   Doctor's advice: 33%
Side effects too severe 41   Side effects too severe: 32%
Did not seem to work 27   Did not seem to work: 21%
Other 25   Other: 19%
Course of treatment ended 15   Course of treatment ended: 12%
Expense 6   Expense: 5%
Personal research 5   Personal research: 4%
Change in health plan coverage 3   Change in health plan coverage: 2%
Not indicated 2   Not indicated: 2%

See all 120 patients who’ve stopped taking Metformin

Currently Taking Metformin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Metformin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Metformin

Always
99 70%
Usually
29 21%
Sometimes
6 4%
Never
7 5%

Burden

Difficulty being on treatment

Burden of Metformin

Very
5 4%
Somewhat
14 10%
A little
29 21%
Not at all
93 66%

Cost

Paid out of pocket

Cost of Metformin

$200+
2 2%
$100-199
1 1%
$50-99
1 1%
$25-49
6 6%
< $25
85 89%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 12, 2012.